FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361904920> ?p ?o ?g. }

• W4361904920 abstract "<p>PDF file - 280KB, Supplementary Table S1. Primers for TP53 genotyping. Supplementary Table S2. Cell lines used as controls for TP53, KRAS, BRAF and PIK3CA genotyping. Supplementary Table S3. Amplification conditions for TP53 genotyping. Supplementary Table S4. Primers for k-RAS, BRAF and PIK3CA genotyping. Supplementary Table S5. Amplification conditions for KRAS, BRAF and PIK3CA genotyping. Supplementary Table S6: Additional clinical and biological characteristics of the patients in the training and validation cohorts, according to EGFR status. Supplementary Table S7: Characteristics of the patients in the training cohort, classified according to EGFR and TP53 status. Supplementary Table S8: List of observed TP53 mutations (training and validation cohorts). Supplementary Table S9: Univariate Cox regression analysis of selected factors for overall survival in the EGFR-wt and EGFR-mut populations of the training cohort. Supplementary Table S10: Results of multivariate analysis of selected factors for overall survival in the EGFR-wt and EGFR-mut groups of the training cohort. Supplementary Table S11: GOF activities in cell line models of some nondisruptive TP53 mutations found in this study. Supplementary Figure S1: Structure of the TP53 protein representing the location of the mutations found in the training cohort. Supplementary Figure S2: Types of TP53 mutations in the training and validation cohorts. Supplementary Figure S3: Distribution of KRAS, BRAF and PIK3CA mutations in the training cohort. Supplementary Figure S4. Kaplan-Meier plots of overall and progression-free survival of the 318 patients in the training cohort, according to EGFR mutational status. Supplementary Figure S5. Kaplan-Meier plots of overall survival of the 125 EGFR-wt patients in the training cohort, according to G12C mutations in K-RAS. Supplementary Figure S6: Kaplan-Meier plots of overall and progression-free survival of the 318 patients in the training cohort, according to TP53 status. Supplementary Figure S7. Kaplan-Meier plots of overall survival of the 110 EGFR-wt patients in the training cohort not carrying G12C mutations in K-RAS. Supplementary Figure S8: Kaplan-Meier plots of progression-free survival of the 318 patients in the training cohort, according to TP53 mutational status. Supplementary Figure S9: Kaplan-Meier plots of progression-free survival in the training cohort, according to EGFR and TP53 mutational status. Supplementary Figure S10: Kaplan-Meier plots of progression-free survival in the training cohort, according to type of treatment.</p>" @default.
• W4361904920 created "2023-04-05" @default.
• W4361904920 creator A5001587695 @default.
• W4361904920 creator A5013884017 @default.
• W4361904920 creator A5019360451 @default.
• W4361904920 creator A5028890927 @default.
• W4361904920 creator A5039171238 @default.
• W4361904920 creator A5040323942 @default.
• W4361904920 creator A5040541281 @default.
• W4361904920 creator A5044887899 @default.
• W4361904920 creator A5055419980 @default.
• W4361904920 creator A5056676096 @default.
• W4361904920 creator A5059355812 @default.
• W4361904920 creator A5062248754 @default.
• W4361904920 creator A5064162399 @default.
• W4361904920 creator A5072758102 @default.
• W4361904920 creator A5080436044 @default.
• W4361904920 creator A5091281351 @default.
• W4361904920 date "2023-03-31" @default.
• W4361904920 modified "2023-10-18" @default.
• W4361904920 title "Supplementary Figures 1 - 10, Tables 1 - 11 from Nondisruptive p53 Mutations Are Associated with Shorter Survival in Patients with Advanced Non–Small Cell Lung Cancer" @default.
• W4361904920 doi "https://doi.org/10.1158/1078-0432.22447548.v1" @default.
• W4361904920 hasPublicationYear "2023" @default.
• W4361904920 type Work @default.
• W4361904920 citedByCount "0" @default.
• W4361904920 crossrefType "posted-content" @default.
• W4361904920 hasAuthorship W4361904920A5001587695 @default.
• W4361904920 hasAuthorship W4361904920A5013884017 @default.
• W4361904920 hasAuthorship W4361904920A5019360451 @default.
• W4361904920 hasAuthorship W4361904920A5028890927 @default.
• W4361904920 hasAuthorship W4361904920A5039171238 @default.
• W4361904920 hasAuthorship W4361904920A5040323942 @default.
• W4361904920 hasAuthorship W4361904920A5040541281 @default.
• W4361904920 hasAuthorship W4361904920A5044887899 @default.
• W4361904920 hasAuthorship W4361904920A5055419980 @default.
• W4361904920 hasAuthorship W4361904920A5056676096 @default.
• W4361904920 hasAuthorship W4361904920A5059355812 @default.
• W4361904920 hasAuthorship W4361904920A5062248754 @default.
• W4361904920 hasAuthorship W4361904920A5064162399 @default.
• W4361904920 hasAuthorship W4361904920A5072758102 @default.
• W4361904920 hasAuthorship W4361904920A5080436044 @default.
• W4361904920 hasAuthorship W4361904920A5091281351 @default.
• W4361904920 hasBestOaLocation W43619049201 @default.
• W4361904920 hasConcept C104317684 @default.
• W4361904920 hasConcept C119857082 @default.
• W4361904920 hasConcept C121608353 @default.
• W4361904920 hasConcept C126322002 @default.
• W4361904920 hasConcept C135763542 @default.
• W4361904920 hasConcept C143998085 @default.
• W4361904920 hasConcept C161584116 @default.
• W4361904920 hasConcept C199163554 @default.
• W4361904920 hasConcept C2776256026 @default.
• W4361904920 hasConcept C2781187634 @default.
• W4361904920 hasConcept C31467283 @default.
• W4361904920 hasConcept C38180746 @default.
• W4361904920 hasConcept C41008148 @default.
• W4361904920 hasConcept C50382708 @default.
• W4361904920 hasConcept C526805850 @default.
• W4361904920 hasConcept C54355233 @default.
• W4361904920 hasConcept C71924100 @default.
• W4361904920 hasConcept C72563966 @default.
• W4361904920 hasConcept C86803240 @default.
• W4361904920 hasConceptScore W4361904920C104317684 @default.
• W4361904920 hasConceptScore W4361904920C119857082 @default.
• W4361904920 hasConceptScore W4361904920C121608353 @default.
• W4361904920 hasConceptScore W4361904920C126322002 @default.
• W4361904920 hasConceptScore W4361904920C135763542 @default.
• W4361904920 hasConceptScore W4361904920C143998085 @default.
• W4361904920 hasConceptScore W4361904920C161584116 @default.
• W4361904920 hasConceptScore W4361904920C199163554 @default.
• W4361904920 hasConceptScore W4361904920C2776256026 @default.
• W4361904920 hasConceptScore W4361904920C2781187634 @default.
• W4361904920 hasConceptScore W4361904920C31467283 @default.
• W4361904920 hasConceptScore W4361904920C38180746 @default.
• W4361904920 hasConceptScore W4361904920C41008148 @default.
• W4361904920 hasConceptScore W4361904920C50382708 @default.
• W4361904920 hasConceptScore W4361904920C526805850 @default.
• W4361904920 hasConceptScore W4361904920C54355233 @default.
• W4361904920 hasConceptScore W4361904920C71924100 @default.
• W4361904920 hasConceptScore W4361904920C72563966 @default.
• W4361904920 hasConceptScore W4361904920C86803240 @default.
• W4361904920 hasLocation W43619049201 @default.
• W4361904920 hasLocation W43619049202 @default.
• W4361904920 hasOpenAccess W4361904920 @default.
• W4361904920 hasPrimaryLocation W43619049201 @default.
• W4361904920 hasRelatedWork W3093444689 @default.
• W4361904920 hasRelatedWork W3093726095 @default.
• W4361904920 hasRelatedWork W3095136102 @default.
• W4361904920 hasRelatedWork W3112877994 @default.
• W4361904920 hasRelatedWork W3144899533 @default.
• W4361904920 hasRelatedWork W4225370667 @default.
• W4361904920 hasRelatedWork W4244435932 @default.
• W4361904920 hasRelatedWork W4285032905 @default.
• W4361904920 hasRelatedWork W4313494932 @default.
• W4361904920 hasRelatedWork W4361918880 @default.
• W4361904920 isParatext "false" @default.
• W4361904920 isRetracted "false" @default.
• W4361904920 workType "article" @default.